
TSE:KBL
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Dividend yield of 4.0% Stable industry growth and good annual recurring revenues. Geographic diversification across Canada and the UK. Opportunity for future acquisitions. Unlock Premium - Try 5i Free
(A Top Pick Jun. 26/17, Down 3%) They have been investing heavily in new plant and equipment. This is a great entry point. They are lowering their costs. They have 30% of the Canadian market and the next biggest player is very weak. There are one time start up costs. This is when you want to invest in these kinds of companies. This is a great entry point and he added to his position recently. You get a great dividend while you wait for higher margins.
There is a lot of weird trading at year-end. You have portfolio managers changing, Short covering, sector reallocation and tax loss selling. He would bet this company’s problem is year-end positioning. A nice solid company. Wouldn't put it in the high growth category. If markets are going to go on a tear, this will underperform. If the market does go down, you are going to be glad you owned it. They sign 10-year facility contracts with their customers.
A very steady business. Just built a new plant in Toronto. There is a potential for them to make an acquisition or to build a plant in Vancouver. His concern is that when they have built plants in the past, it’s taken time to fill the capacity of them. He is cautious. On top of that it has always been pricey as a stock. Hard to see where the upside is in terms of valuation. Dividend yield of 3.1%.
Their business has moved more into healthcare. Last year was hit by extreme gas price movements in the UK. He thought they were protected from inflation when he bought it, though. A stable, underknown business that cranks out cash flow. Likes management.